Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma.

Wakamatsu T, Kakunaga S, Takenaka S, Outani H, Hamada K, Imura Y, Hori Y, Naka N, Kudawara I, Yoshikawa H, Ueda T.

Int J Clin Oncol. 2019 Jun 13. doi: 10.1007/s10147-019-01475-1. [Epub ahead of print]

PMID:
31197555
2.

Osteosarcoma in patients over 50 years of age: Multi-institutional retrospective analysis of 104 patients.

Nagano A, Matsumoto S, Kawai A, Okuma T, Hiraga H, Matsumoto Y, Nishida Y, Yonemoto T, Hosaka M, Takahashi M, Yoshikawa H, Kunisada T, Asanuma K, Naka N, Emori M, Kubo T, Kawashima H, Kawamoto T, Yokoyama R, Tsukushi S, Sato K, Okamoto T, Hiraoka K, Morioka H, Tanaka K, Takagi T, Iwamoto Y, Ozaki T.

J Orthop Sci. 2019 May 30. pii: S0949-2658(19)30128-9. doi: 10.1016/j.jos.2019.04.008. [Epub ahead of print]

PMID:
31155441
3.

Survival analysis of elderly patients with osteosarcoma.

Imura Y, Takenaka S, Kakunaga S, Nakai T, Wakamatsu T, Outani H, Tanaka T, Tamiya H, Oshima K, Hamada K, Naka N, Araki N, Kudawara I, Ueda T, Yoshikawa H.

Int Orthop. 2019 Jul;43(7):1741-1747. doi: 10.1007/s00264-019-04332-y. Epub 2019 Apr 22.

PMID:
31011764
4.

Rectotumoral fistula formation occurring more than 5 years after carbon ion radiotherapy for sacral chordoma: A case report.

Ukon Y, Outani H, Nagata S, Konishi E, Imai R, Demizu Y, Okimoto T, Naka N, Araki N.

Mol Clin Oncol. 2019 May;10(5):487-491. doi: 10.3892/mco.2019.1821. Epub 2019 Mar 5.

5.

Frequent mutations of genes encoding vacuolar H+ -ATPase components in granular cell tumors.

Sekimizu M, Yoshida A, Mitani S, Asano N, Hirata M, Kubo T, Yamazaki F, Sakamoto H, Kato M, Makise N, Mori T, Yamazaki N, Sekine S, Oda I, Watanabe SI, Hiraga H, Yonemoto T, Kawamoto T, Naka N, Funauchi Y, Nishida Y, Honoki K, Kawano H, Tsuchiya H, Kunisada T, Matsuda K, Inagaki K, Kawai A, Ichikawa H.

Genes Chromosomes Cancer. 2019 Jun;58(6):373-380. doi: 10.1002/gcc.22727. Epub 2019 Jan 21.

PMID:
30597645
6.

Clinical outcomes and significant factors in the survival rate after decompression surgery for patients who were non-ambulatory due to spinal metastases.

Tateiwa D, Oshima K, Nakai T, Imura Y, Tanaka T, Outani H, Tamiya H, Araki N, Naka N.

J Orthop Sci. 2019 Mar;24(2):347-352. doi: 10.1016/j.jos.2018.10.003. Epub 2018 Oct 25.

PMID:
30482604
7.

Superradiance-to-Polariton Crossover of Wannier Excitons with Multiple Resonances.

Takahata M, Tanaka K, Naka N.

Phys Rev Lett. 2018 Oct 26;121(17):173604. doi: 10.1103/PhysRevLett.121.173604.

PMID:
30411910
8.

Endoprosthetic Reconstruction for a Displaced Atypical Femoral Fracture in a Cancer Patient with Poor Prognosis.

Tamiya H, Hagizawa H, Nakai T, Imura Y, Tanaka T, Oshima K, Ito T, Naka N, Kuratsu S.

Case Rep Orthop. 2018 Sep 20;2018:7862516. doi: 10.1155/2018/7862516. eCollection 2018.

9.

A pseudoaneurysm of the popliteal artery probably pierced by a bone spike arising in the spontaneously regressed osteochondroma: A case report.

Yasuda N, Nakai S, Nakai T, Outani H, Takenaka S, Hamada KI, Matsunobu T, Yoshikawa H, Naka N.

J Orthop Sci. 2018 Oct 11. pii: S0949-2658(18)30253-7. doi: 10.1016/j.jos.2018.09.006. [Epub ahead of print] No abstract available.

PMID:
30318426
10.

Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304.

Tanaka K, Ogawa G, Mizusawa J, Naka N, Kawai A, Takahashi M, Hiruma T, Matsumoto Y, Tsuchiya H, Nakayama R, Hatano H, Emori M, Hosaka M, Yoshida Y, Toguchida J, Abe S, Asanuma K, Yokoyama R, Hiraga H, Yonemoto T, Morii T, Matsumoto S, Nagano A, Yoshikawa H, Fukuda H, Ozaki T, Iwamoto Y.

World J Surg Oncol. 2018 Aug 10;16(1):162. doi: 10.1186/s12957-018-1462-y.

11.

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study.

Urakawa H, Yonemoto T, Matsumoto S, Takagi T, Asanuma K, Watanuki M, Takemoto A, Naka N, Matsumoto Y, Kawai A, Kunisada T, Kubo T, Emori M, Hiraga H, Hatano H, Tsukushi S, Nishida Y, Akisue T, Morii T, Takahashi M, Nagano A, Yoshikawa H, Sato K, Kawano M, Hiraoka K, Tanaka K, Iwamoto Y, Ozaki T.

World J Surg Oncol. 2018 Aug 8;16(1):160. doi: 10.1186/s12957-018-1459-6.

12.

Clinical Features and Prognosis of Patients With the Bone Metastasis of Pancreatic Cancer: A Single-Institutional Cohort Study.

Outani H, Akita H, Nakai T, Takada R, Imura Y, Tanaka T, Tamiya H, Oshima K, Takahashi H, Ohkawa K, Katayama K, Araki N, Naka N.

Pancreas. 2018 Aug;47(7):e43-e46. doi: 10.1097/MPA.0000000000001098. No abstract available.

PMID:
29985850
13.

Calcific myonecrosis mimicking soft tissue sarcoma: A case report.

Ukon Y, Tanaka T, Nagata S, Hagizawa H, Imura Y, Tamiya H, Oshima K, Naka N, Aoki Y, Kuratsu S.

Oncol Lett. 2018 May;15(5):7909-7913. doi: 10.3892/ol.2018.8320. Epub 2018 Mar 22.

14.

Atypical femoral fracture associated with bone-modifying agent for bone metastasis of breast cancer: A report of two cases.

Tateiwa D, Outani H, Iwasa S, Imura Y, Tanaka T, Oshima K, Naka N, Araki N.

J Orthop Surg (Hong Kong). 2017 Sep-Dec;25(3):2309499017727916. doi: 10.1177/2309499017727916.

PMID:
28844196
15.

Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis.

Outani H, Imura Y, Tanaka T, Takenaka S, Oshima K, Hamada K, Kakunaga S, Joyama S, Naka N, Kudawara I, Ueda T, Araki N, Yoshikawa H.

Int J Clin Oncol. 2018 Feb;23(1):181-188. doi: 10.1007/s10147-017-1179-x. Epub 2017 Aug 10.

PMID:
28799063
16.

Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.

Nakai T, Imura Y, Tamiya H, Yamada S, Nakai S, Yasuda N, Kaneko K, Outani H, Takenaka S, Hamada K, Myoui A, Araki N, Ueda T, Itoh K, Yoshikawa H, Naka N.

Cancer Med. 2017 Sep;6(9):2121-2130. doi: 10.1002/cam4.1130. Epub 2017 Jul 26.

17.

Therapeutic potential of TAS-115 via c-MET and PDGFRα signal inhibition for synovial sarcoma.

Yamada S, Imura Y, Nakai T, Nakai S, Yasuda N, Kaneko K, Outani H, Takenaka S, Hamada K, Myoui A, Araki N, Ueda T, Itoh K, Yoshikawa H, Naka N.

BMC Cancer. 2017 May 16;17(1):334. doi: 10.1186/s12885-017-3324-3.

18.

Functional and therapeutic relevance of hepatocyte growth factor/c-MET signaling in synovial sarcoma.

Imura Y, Nakai T, Yamada S, Outani H, Takenaka S, Hamada K, Araki N, Itoh K, Yoshikawa H, Naka N.

Cancer Sci. 2016 Dec;107(12):1867-1876. doi: 10.1111/cas.13092. Epub 2016 Dec 19.

19.

A case report of pancreatic metastasis from synovial sarcoma successfully treated by metastasectomy with adjuvant chemotherapy.

Makino Y, Shigekawa M, Kegasawa T, Suda T, Yoshioka T, Iwahashi K, Ikezawa K, Sakamori R, Yakushijin T, Kajihara J, Tomimaru Y, Eguchi H, Imura Y, Outani H, Naka N, Honma K, Morii E, Tatsumi T, Hiramatsu N, Takehara T.

Medicine (Baltimore). 2016 Sep;95(39):e4789. doi: 10.1097/MD.0000000000004789.

20.

Radiofrequency ablation of osteoid osteoma using a three-dimensional navigation system.

Outani H, Hamada K, Takenaka S, Imura Y, Oshima K, Sotobori T, Naka N, Araki N, Yoshikawa H, Myoui A.

J Orthop Sci. 2016 Sep;21(5):678-82. doi: 10.1016/j.jos.2016.05.005. Epub 2016 Jun 16.

PMID:
27320819
21.

Trabectedin is a promising antitumour agent for synovial sarcoma.

Yasui H, Imura Y, Outani H, Hamada K, Nakai T, Yamada S, Takenaka S, Sasagawa S, Araki N, Itoh K, Myoui A, Yoshikawa H, Naka N.

J Chemother. 2016 Oct;28(5):417-24. doi: 10.1080/1120009X.2015.1133013. Epub 2016 Jan 29.

PMID:
27077926
22.

Treatment outcomes of Japanese patients with Ewing sarcoma: differences between skeletal and extraskeletal Ewing sarcoma.

Takenaka S, Naka N, Obata H, Joyama S, Hamada K, Imura Y, Kakunaga S, Aoki Y, Ueda T, Araki N, Yoshikawa H.

Jpn J Clin Oncol. 2016 Jun;46(6):522-8. doi: 10.1093/jjco/hyw032. Epub 2016 Mar 23.

PMID:
27008849
23.

A case of adolescent giant parathyroid adenoma presenting multiple osteolytic fractures and postoperative hungry bone syndrome.

Ebina K, Miyoshi Y, Izumi S, Hashimoto J, Naka N, Tsukamoto Y, Kashii M, Kaito T, Yoshikawa H.

Clin Case Rep. 2015 Oct;3(10):835-40. doi: 10.1002/ccr3.360. Epub 2015 Sep 2.

24.

Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.

Outani H, Hamada K, Imura Y, Oshima K, Sotobori T, Demizu Y, Kakunaga S, Joyama S, Imai R, Okimoto T, Naka N, Kudawara I, Ueda T, Araki N, Kamada T, Yoshikawa H.

Int J Clin Oncol. 2016 Feb;21(1):186-93. doi: 10.1007/s10147-015-0870-z. Epub 2015 Jul 7.

PMID:
26150259
25.

Intraoperative extracorporeal autogenous irradiated tendon grafts for functional limb salvage surgery of soft tissue sarcomas of the wrist and hand.

Omori S, Hamada K, Outani H, Oshima K, Joyama S, Tomita Y, Naka N, Araki N, Yoshikawa H.

World J Surg Oncol. 2015 May 12;13:179. doi: 10.1186/s12957-015-0588-4.

26.

Clinical outcomes for patients with synovial sarcoma of the hand.

Outani H, Hamada K, Oshima K, Joyama S, Naka N, Araki N, Ueda T, Yoshikawa H.

Springerplus. 2014 Nov 3;3:649. doi: 10.1186/2193-1801-3-649. eCollection 2014.

27.

A giant periosteal chondroma of the distal femur successfully reconstructed with synthetic bone grafts and a bioresorbable plate: a case report.

Imura Y, Shigi A, Outani H, Hamada K, Tamura H, Morii E, Myoui A, Yoshikawa H, Naka N.

World J Surg Oncol. 2014 Nov 22;12:354. doi: 10.1186/1477-7819-12-354.

28.

Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma.

Imura Y, Yasui H, Outani H, Wakamatsu T, Hamada K, Nakai T, Yamada S, Myoui A, Araki N, Ueda T, Itoh K, Yoshikawa H, Naka N.

Mol Cancer. 2014 Aug 7;13:185. doi: 10.1186/1476-4598-13-185.

29.

Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.

Wakamatsu T, Naka N, Sasagawa S, Tanaka T, Takenaka S, Araki N, Ueda T, Nishizawa Y, Yoshikawa H, Itoh K.

Cancer Sci. 2014 Sep;105(9):1124-34. doi: 10.1111/cas.12469. Epub 2014 Sep 3.

30.

Expression of noggin, an antagonist of bone morphogenetic protein, in schwannoma: A possible mechanism.

Kaneko K, Higuchi C, Naka N, Yoshikawa H.

Oncol Lett. 2014 Jul;8(1):111-116. Epub 2014 May 12.

31.

Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.

Outani H, Tanaka T, Wakamatsu T, Imura Y, Hamada K, Araki N, Itoh K, Yoshikawa H, Naka N.

BMC Cancer. 2014 Jun 19;14:455. doi: 10.1186/1471-2407-14-455.

32.

Long-term results of intraoperative extracorporeal irradiation of autogenous bone grafts on primary bone and soft tissue malignancies.

Hayashi K, Araki N, Koizumi M, Suzuki O, Seo Y, Naka N, Isohashi F, Myoui A, Yoshioka Y, Teshima T, Ueda T, Yoshikawa H, Ogawa K.

Acta Oncol. 2015 Jan;54(1):138-41. doi: 10.3109/0284186X.2014.930172. Epub 2014 Jun 16. No abstract available.

PMID:
24930390
33.

Intercalary endoprosthesis for salvage of failed intraoperative extracorporeal autogeneous irradiated bone grafting (IORBG) reconstruction.

Hamada K, Naka N, Omori S, Outani H, Oshima K, Joyama S, Araki N, Yoshikawa H.

J Surg Case Rep. 2014 Mar 7;2014(3). pii: rju014. doi: 10.1093/jscr/rju014.

34.

Tailored therapeutic strategies for synovial sarcoma: receptor tyrosine kinase pathway analyses predict sensitivity to the mTOR inhibitor RAD001.

Yasui H, Naka N, Imura Y, Outani H, Kaneko K, Hamada K, Sasagawa S, Araki N, Ueda T, Itoh K, Myoui A, Yoshikawa H.

Cancer Lett. 2014 May 28;347(1):114-22. doi: 10.1016/j.canlet.2014.01.027. Epub 2014 Jan 31.

PMID:
24491407
35.

Favorable outcome after complete resection in elderly soft tissue sarcoma patients: Japanese Musculoskeletal Oncology Group study.

Yoneda Y, Kunisada T, Naka N, Nishida Y, Kawai A, Morii T, Takeda K, Hasei J, Yamakawa Y, Ozaki T; Japanese Musculoskeletal Oncology Group.

Eur J Surg Oncol. 2014 Jan;40(1):49-54. doi: 10.1016/j.ejso.2013.09.004. Epub 2013 Sep 13.

PMID:
24075825
36.

Slow-growing primary marginal zone B-cell lymphoma arising in the chest wall in a patient without a history of tuberculosis.

Ueda K, Nakanishi K, Satoh Y, Sakai M, Naka N, Araki N, Tomita Y, Tomiyama N.

Acta Radiol Short Rep. 2013 Mar 18;2(2):2047981613477402. doi: 10.1177/2047981613477402. eCollection 2013.

37.

A novel angiomatoid epithelioid sarcoma cell line, Asra-EPS, forming tumors with large cysts containing hemorrhagic fluid in vivo.

Imura Y, Naka N, Outani H, Yasui H, Takenaka S, Hamada K, Ozaki R, Kaya M, Yoshida K, Morii E, Myoui A, Yoshikawa H.

BMC Res Notes. 2013 Aug 1;6:305. doi: 10.1186/1756-0500-6-305.

38.

Observation of excitonic N-body bound states: polyexcitons in diamond.

Omachi J, Suzuki T, Kato K, Naka N, Yoshioka K, Kuwata-Gonokami M.

Phys Rev Lett. 2013 Jul 12;111(2):026402. Epub 2013 Jul 9.

PMID:
23889423
39.

[A case of malignant lymphoma in the pelvis suspected to be a neurogenic tumor].

Soda T, Okumi M, Miyagawa Y, Naka N, Tsujimura A, Nonomura N.

Hinyokika Kiyo. 2013 May;59(5):293-6. Japanese.

40.

Bone tissue engineering with bone marrow-derived stromal cells integrated with concentrated growth factor in Rattus norvegicus calvaria defect model.

Honda H, Tamai N, Naka N, Yoshikawa H, Myoui A.

J Artif Organs. 2013 Sep;16(3):305-15. doi: 10.1007/s10047-013-0711-7. Epub 2013 May 23.

PMID:
23700004
41.

Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.

Kudawara I, Aoki Y, Ueda T, Araki N, Naka N, Nakanishi H, Matsumine A, Ieguchi M, Mori S, Myoui A, Kuratsu S, Hashimoto N, Yoshikawa H.

J Chemother. 2013 Feb;25(1):41-8. doi: 10.1179/1973947812Y.0000000055.

PMID:
23433444
42.

A new strategy to remove broken femoral mega-prostheses with hollow trephine reamers.

Tanaka T, Hamada K, Oshima K, Joyama S, Naka N, Araki N.

Eur J Orthop Surg Traumatol. 2013 Apr;23(3):357-60. doi: 10.1007/s00590-012-0974-3. Epub 2012 Mar 28.

PMID:
23412286
43.

Compartment syndrome of the arm caused by transcatheter angiography or angioplasty.

Omori S, Miyake J, Hamada K, Naka N, Araki N, Yoshikawa H.

Orthopedics. 2013 Jan;36(1):e121-5. doi: 10.3928/01477447-20121217-31.

PMID:
23276344
44.

Dynamic analysis of lung metastasis by mouse osteosarcoma LM8: VEGF is a candidate for anti-metastasis therapy.

Tanaka T, Yui Y, Naka N, Wakamatsu T, Yoshioka K, Araki N, Yoshikawa H, Itoh K.

Clin Exp Metastasis. 2013 Apr;30(4):369-79. doi: 10.1007/s10585-012-9543-8. Epub 2012 Oct 18.

45.

Synovial chondromatosis of the metacarpophalangeal joint: a case report and literature review.

Tominaga A, Takenaka S, Murase T, Hashimoto N, Naka N, Yoshikawa H.

Hand Surg. 2012;17(3):395-8. doi: 10.1142/S0218810412720409. Review.

PMID:
23061954
46.
47.

Surgery with vascular reconstruction for soft-tissue sarcomas in the inguinal region: oncologic and functional outcomes.

Emori M, Hamada K, Omori S, Joyama S, Tomita Y, Hashimoto N, Takami H, Naka N, Yoshikawa H, Araki N.

Ann Vasc Surg. 2012 Jul;26(5):693-9. doi: 10.1016/j.avsg.2011.12.003.

PMID:
22664282
48.

[II. Possibility of molecular targeting therapy for musculoskeletal cancer].

Naka N.

Gan To Kagaku Ryoho. 2012 Mar;39(3):373-7. Review. Japanese. No abstract available.

PMID:
22619772
49.

In-situ cathodoluminescence spectroscopy of silicon oxide thin film under uniaxial tensile loading.

Namazu T, Yamashita N, Kakinuma S, Nishikata K, Naka N, Matsumoto K, Inoue S.

J Nanosci Nanotechnol. 2011 Apr;11(4):2861-6.

PMID:
21776644
50.

Case of an unusual clinical and radiological presentation of pulmonary metastasis from a costal chondrosarcoma after wide surgical resection: a transbronchial biopsy is recommended.

Emori M, Hamada K, Kozuka T, Nakanishi K, Tomita Y, Naka N, Araki N.

World J Surg Oncol. 2011 May 16;9:50. doi: 10.1186/1477-7819-9-50.

Supplemental Content

Support Center